‘Everybody’ with breast cancer should undergo genomic testing for BRCA mutations

All women with breast cancer should undergo genetic testing for BRCA1 and BRCA2 mutations, according to study findings presented at San Antonio Breast Cancer Symposium.
BRCA testing guidelines rely on age and the types, aggressiveness and quantity of cancers in a family, but results from the City of Hope’s Implementing Next-generation Sequencing for Precision Intervention and Risk Evaluation (INSPIRE) study showed strictly relying on those guidelines would preclude many women from getting treatment that need it, Joanne Mortimer, MD, FACP, FASCO, professor and vice chair of the department

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart